![Jacquelyn Sandell](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jacquelyn Sandell
General Counsel at
JOUNCE THERAPEUTICS, INC.
Net worth: 93 261 $ as of 2026-09-29
Profile
Jacquelyn Fahey Sandell is currently Secretary & Chief Legal Officer at Jounce Therapeutics, Inc. since 2019 and Chief Legal Officer at Voyager Therapeutics, Inc. since 2023.
Formerly, Ms. Sandell was Associate General Counsel at Millennium Pharmaceuticals, Inc. from 2011 to 2015, Vice President & General Counsel at Vericel Corp., and Senior Corporate Counsel at Genzyme Corp.
from 2005 to 2011.
Education includes undergraduate studies at Duke University and graduate studies at Boston University School of Law.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-03-30 | 34,799 ( 0.06% ) | 93 261 $ | 2026-09-29 |
Jacquelyn Sandell active positions
| Companies | Position | Start |
|---|---|---|
| JOUNCE THERAPEUTICS, INC. | General Counsel | 2019-09-16 |
Former positions of Jacquelyn Sandell
| Companies | Position | End |
|---|---|---|
| VOYAGER THERAPEUTICS, INC. | General Counsel | 2025-11-30 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Corporate Officer/Principal | 2014-12-31 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | General Counsel | 2010-12-31 |
| VERICEL CORPORATION | General Counsel | - |
Education of Jacquelyn Sandell
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
67
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Vericel Corp.
 Vericel Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which manufactures and markets two advanced cell therapy products for sports medicine and severe burn care | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston University School of Law
 Boston University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Jounce Therapeutics, Inc.
 Jounce Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immunotherapy company that develops therapies to treat cancer | Health Technology |
Voyager Therapeutics, Inc.
 Voyager Therapeutics, Inc. BiotechnologyHealth Technology Develops gene therapies for fatal and debilitating diseases of the central nervous system | Health Technology |
- Stock Market
- Insiders
- Jacquelyn Sandell
